Canada markets closed

FibroBiologics, Inc. (SG0.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
11.30-0.50 (-4.24%)
At close: 08:03AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
2,850
2,368
1,147
521
Selling General and Administrative
7,224
6,521
3,320
1,057
Total Operating Expenses
10,074
8,889
4,467
1,578
Operating Income or Loss
-10,074
-8,889
-4,467
-1,578
Interest Expense
16
147
654
4
Total Other Income/Expenses Net
-12,479
-7,449
-
-
Income Before Tax
-22,530
-16,485
-5,121
-1,582
Income from Continuing Operations
-22,530
-16,485
-5,121
-1,582
Net Income
-22,530
-16,485
-5,121
-1,582
Net Income available to common shareholders
-22,530
-19,058
-5,121
-1,582
Basic EPS
-0.59
-0.59
-0.16
-0.05
Diluted EPS
-0.59
-0.59
-0.16
-0.05
Basic Average Shares
32,492
32,492
32,477
32,477
Diluted Average Shares
32,492
32,492
32,477
32,477